Biocon Launches Bifunctional Antibody IO Subsidiary Bicara with $40 Million Biospace, 15 Mar 2021 Bicara CEO Claire Mazumdar, Courtesy of Bicara Therapeutics Cambridge-based Bicara Therapeutics launched with a $40 million…